ORION BIOTECH OPPORTUNTES CO's ticker is ORIAU and the CUSIP is G6780C125.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $914,355 | -50.1% | 93,780 | -50.0% | 0.08% | +1.2% |
| Q4 2022 | $1,832,462 | +98.3% | 187,560 | +100.0% | 0.08% | -7.7% |
| Q3 2022 | $924,000 | +1.4% | 93,780 | 0.0% | 0.09% | +2.2% |
| Q2 2022 | $911,000 | -0.5% | 93,780 | 0.0% | 0.09% | +4.7% |
| Q1 2022 | $916,000 | -1.2% | 93,780 | -1.3% | 0.08% | +1.2% |
| Q4 2021 | $927,000 | – | 95,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JNE Partners LLP | 1,500,000 | $14,655,000 | 10.14% |
| GRITSTONE ASSET MANAGEMENT LLC | 16,338 | $159,622 | 0.20% |
| Schechter Investment Advisors, LLC | 187,560 | $1,832,462 | 0.08% |
| 683 Capital Management, LLC | 1,000 | $9,770 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| CLEAR STREET LLC | 300 | $3 | 0.00% |
| UBS Group AG | 127 | $1,241 | 0.00% |